• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于局部作用的皮肤给药的新型大麻二酚微乳凝胶的生物制药特性的开发与优化。

Development and optimisation of biopharmaceutical properties of a new microemulgel of cannabidiol for locally-acting dermatological delivery.

作者信息

Vanti Giulia, Grifoni Lucia, Bergonzi Maria Camilla, Antiga Emiliano, Montefusco Francesca, Caproni Marzia, Bilia Anna Rita

机构信息

Department of Chemistry, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, FI, Italy.

Department of Health Sciences, Section of Dermatology, University of Florence, Viale Michelangiolo 41, 50125 Florence, Italy.

出版信息

Int J Pharm. 2021 Sep 25;607:121036. doi: 10.1016/j.ijpharm.2021.121036. Epub 2021 Aug 23.

DOI:10.1016/j.ijpharm.2021.121036
PMID:34438005
Abstract

Cannabidiol (CBD) is a pleiotropic phytocannabinoid, recently investigated to treat many skin diseases. This study aimed to develop a CBD-loaded O/A microemulsion (CBD-ME) formulated as microemulgel (CBD-MEgel), suitable for local administration. The developed CBD-ME consisted of Solutol HS 15 (20%, surfactant), Transcutol P (9%, cosolvent), isopropyl myristate (5%, oil phase), water (66%) and 1% w/w CBD. Globules had polydispersity index less than 0.23 ± 0.02 and size of 35 ± 2 nm; these values did not change after loading CBD and gelling the formulation with Sepigel 305 obtaining a clear and homogeneous formulation with a pH of 6.56 ± 0.20, suitable for cutaneous application. Viscosity properties were investigated by the rotational digital viscometer, at both 21 ± 2 °C and 35 ± 2 °C. Viscosities of CBD-MEgel were 439,000 ± 4,243 mPa·s and 391,000 ± 1,414 mPa·s respectively. The release studies displayed that 90 ± 24 μg/cm of CBD were released in 24 h. The CBD permeability, evaluated using Franz diffusion cells and rabbit ear skin, was 3 ± 1 μg/cm. Skin-PAMPA gave a CBD effective permeability of (1.67 ± 0.16) ·10 cm/s and an absorbed dose of 115.30 ± 16.99 µg/cm after 24 h. Lastly, physical and chemical stability of both CBD-ME and CBD-MEgel were evaluated over a period of 3 months, showing optimal shelf-life at the storage conditions.

摘要

大麻二酚(CBD)是一种具有多种效应的植物大麻素,最近被研究用于治疗多种皮肤疾病。本研究旨在开发一种负载CBD的油包水(O/A)微乳(CBD-ME),并将其制成适合局部给药的微乳凝胶(CBD-MEgel)。所制备的CBD-ME由聚氧乙烯蓖麻油氢化蓖麻油15(20%,表面活性剂)、二乙二醇单乙醚(9%,助溶剂)、肉豆蔻酸异丙酯(5%,油相)、水(66%)和1% w/w的CBD组成。微球的多分散指数小于0.23±0.02,粒径为35±2 nm;在负载CBD并用Sepigel 305使制剂胶凝后,这些值没有变化,得到了一种澄清均匀的制剂,pH值为6.56±0.20,适合皮肤应用。使用旋转数字粘度计在21±2℃和35±2℃下研究了粘度特性。CBD-MEgel的粘度分别为439,000±4,243 mPa·s和391,000±1,414 mPa·s。释放研究表明,在24小时内释放出90±24μg/cm的CBD。使用Franz扩散池和兔耳皮肤评估的CBD渗透率为3±1μg/cm。皮肤平行人工膜渗透试验(Skin-PAMPA)显示,CBD的有效渗透率为(1.67±0.16)·10 cm/s,并在24小时后吸收剂量为115.30±16.99μg/cm。最后,对CBD-ME和CBD-MEgel的物理和化学稳定性进行了3个月的评估,结果表明在储存条件下具有最佳保质期。

相似文献

1
Development and optimisation of biopharmaceutical properties of a new microemulgel of cannabidiol for locally-acting dermatological delivery.用于局部作用的皮肤给药的新型大麻二酚微乳凝胶的生物制药特性的开发与优化。
Int J Pharm. 2021 Sep 25;607:121036. doi: 10.1016/j.ijpharm.2021.121036. Epub 2021 Aug 23.
2
Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.羟丙基-β-环糊精与微乳剂联合用于酮康唑的协同皮肤靶向作用
Eur J Pharm Biopharm. 2015 Jun;93:136-48. doi: 10.1016/j.ejpb.2015.03.028. Epub 2015 Apr 4.
3
In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils.体外经皮吸收研究大麻二酚的方法:探讨药物浓度、化学增强剂和精油的影响。
Int J Pharm. 2022 Mar 25;616:121540. doi: 10.1016/j.ijpharm.2022.121540. Epub 2022 Feb 4.
4
Formulation and In Vitro-Ex vivo Evaluation of Cannabidiol and Cannabidiol-Valine-Hemisuccinate Loaded Lipid-Based Nanoformulations for Ocular Applications.用于眼部应用的载有大麻二酚和大麻二酚-缬氨酸-半琥珀酸酯的基于脂质的纳米制剂的配方和体外-体内评价。
Int J Pharm. 2024 May 25;657:124110. doi: 10.1016/j.ijpharm.2024.124110. Epub 2024 Apr 10.
5
Evaluations of Skin Permeability of Cannabidiol and Its Topical Formulations by Skin Membrane-Based Parallel Artificial Membrane Permeability Assay and Franz Cell Diffusion Assay.通过基于皮肤膜的平行人工膜渗透试验和弗兰兹细胞扩散试验评估大麻二酚及其外用制剂的皮肤渗透性。
Med Cannabis Cannabinoids. 2022 Oct 10;5(1):129-137. doi: 10.1159/000526769. eCollection 2022 Jan-Dec.
6
Development and Evaluation of Khellin-loaded Microemulgel for Dermatological Applications.载有荆芥宁的微乳凝胶的研制与评价。
Planta Med. 2023 Jul;89(8):848-855. doi: 10.1055/a-1789-3112. Epub 2022 Mar 4.
7
Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.经皮递送酮康唑微乳作为载体:制剂、评价及囊泡-皮肤相互作用。
Int J Pharm. 2014 Apr 25;465(1-2):120-31. doi: 10.1016/j.ijpharm.2014.02.012. Epub 2014 Feb 12.
8
Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.具有改善皮肤渗透性和抗皱效果的营养保健品辅酶Q10纳米乳剂的优化
Drug Dev Ind Pharm. 2018 Feb;44(2):316-328. doi: 10.1080/03639045.2017.1391836. Epub 2017 Nov 2.
9
Transdermal delivery enhancement of carvacrol from Origanum vulgare L. essential oil by microemulsion.微乳增强牛至精油香芹酚的透皮传递。
Int J Pharm. 2020 Apr 15;579:119052. doi: 10.1016/j.ijpharm.2020.119052. Epub 2020 Jan 23.
10
Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization,andevaluation.用于直接经鼻向脑递药的大麻二酚纳米乳的研制:统计优化及评价。
Biomed Mater. 2022 Sep 28;17(6). doi: 10.1088/1748-605X/ac9267.

引用本文的文献

1
Medicine 2.0: Nanotechnology-Based Delivery Systems for Synthetic and Chemically Modified Cannabinoids for Enhanced Therapeutic Performance.医学2.0:基于纳米技术的合成及化学修饰大麻素递送系统,以增强治疗效果。
Nanomaterials (Basel). 2025 Aug 15;15(16):1260. doi: 10.3390/nano15161260.
2
A Novel Glucosamine-Based Cannabidiol Complex Based on Intermolecular Bonding with Improved Water Solubility.一种基于分子间键合且具有改善水溶性的新型氨基葡萄糖-大麻二酚复合物。
Molecules. 2025 Jul 29;30(15):3179. doi: 10.3390/molecules30153179.
3
Optimization of Anthralin Microemulgel Targeted Delivery for Psoriasis and Acne.用于银屑病和痤疮的蒽林微乳凝胶靶向递送的优化
Molecules. 2025 Jun 17;30(12):2629. doi: 10.3390/molecules30122629.
4
Environmentally Friendly Microemulsions of Essential Oils of and to Protect Crops against .用于保护作物免受[病害名称]侵害的[植物名称1]和[植物名称2]精油的环境友好型微乳液。
Nanomaterials (Basel). 2024 Oct 27;14(21):1715. doi: 10.3390/nano14211715.
5
Liver-Targeted Nanoparticles Loaded with Cannabidiol Based on Redox Response for Effective Alleviation of Acute Liver Injury.基于氧化还原响应的负载大麻二酚的肝靶向纳米颗粒用于有效减轻急性肝损伤
Foods. 2024 Aug 4;13(15):2464. doi: 10.3390/foods13152464.
6
Comprehensive Insight into Cutaneous Application of Hemp.对大麻皮肤应用的全面洞察。
Pharmaceutics. 2024 May 31;16(6):748. doi: 10.3390/pharmaceutics16060748.
7
Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from for Topical Administration.一种含大麻二酚油和来自[具体来源未给出]的亲水性提取物的微乳剂的开发与表征,用于局部给药。
Pharmaceutics. 2024 May 24;16(6):705. doi: 10.3390/pharmaceutics16060705.
8
Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature.经皮给予大麻二酚治疗急性炎症性疼痛:文献全面综述。
Int J Mol Sci. 2024 May 28;25(11):5858. doi: 10.3390/ijms25115858.
9
Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations.局部应用胶体制剂后,大麻二酚在人体皮肤中的经皮递送和生物分布。
Pharmaceutics. 2024 Jan 30;16(2):202. doi: 10.3390/pharmaceutics16020202.
10
Cannabidiol-loaded microparticles embedded in a porous hydrogel matrix for biomedical applications.载有大麻二酚的微粒嵌入多孔水凝胶基质中,用于生物医学应用。
J Mater Sci Mater Med. 2024 Feb 14;35(1):14. doi: 10.1007/s10856-023-06773-9.